We have observed
5 EP applications
Eva Susanne Ehlich
has served for within the last five+ years.
(We consider all applications which have an EP A1 or A2 publication dated after February 23, 2013).
Please note, that we only count EP applications,
in which the name of the patent attorney is explicitly mentioned as representative.
These EP applications are:
Transdermal therapeutic system for administering the active substance buprenorphine
PHARMACEUTICAL DOSAGE FORMS COMPRISING POLY (EPSILON- CAPROLACTONE) AND POLYETHYLENE OXIDE
Transdermal delivery system
IMPROVED ENTERIC ACTIVE SUBSTANCE DELIVERY
METHOD FOR MANUFACTURING ELECTRICAL DOUBLE LAYER CAPACITOR ELECTRODES